ICYMI, some of this week’s featured content includes an exclusive interview the NFCMMD symposium, and articles on ruxolitinib, what to watch in the psoriasis pipeline, and more.
People are born with sterile skin and then gain microbiota throughout their life. Lawrence J. Green, MD, FAAD, explains how this affects the skin barrier and ultimately plays a role in atopic dermatitis at the 2021 Fall Clinical Dermatology Conference.
Unlike Caucasian patients who are primarily concerned about the acne itself, skin of color patients prioritize postinflammatory hyperpigmentation.
Botulinum type A injections are widely used across the dermatology and aesthetic medicine specialties. At the Fall Clinical Dermatology Conference 2021, Mark S Nestor, MD, PhD, highlights how to optimize the neurotoxin to improve patient care.
FDA approval of ruxolitinib (Opzelura, Incyte) adds the first new topical anti-inflammatory to the atopic dermatitis (AD) armamentarium in 50 years, but boxed warnings raise questions.
Mark G. Lebwohl, MD, presents on what dermatologists need to know about the newest psoriasis studies during the Fall Clinical Dermatology Conference.
In this episode of DermView, Adelaide Hebert, MD, explains the clinical manifestations of eczema, how the chronic the condition is, and the benefits of using ceramide cream for management.
Investigators recommended a treatment course of at least 1-2 months with medium strength to potent topical corticosteroids should be considered before dupilumab discontinuation in affected children and adolescents.
In this month's OJM Group video series, Jason O'Dell, MS, CWM explains cash balance plans.
Patients treated with the monoclonal antibody had increased incidences of conjunctivitis, though many of these incidences were considered mild and were resolved by the end of the study.
In this video, we talk to Michael Gold, MD, about the 11th annual New Frontiers in Cosmetic Medicine and Medical Dermatology symposium. He tells us the highlights of the conference and what makes it stands out from the rest.
The assumption has been that the COVID-19 pandemic has been at the root of recent upticks in physician burnout.
In this week’s Pointers with Dr Portela, the 208SkinDoc watches a TikTok and debunks its claim of what causes brown spots.
Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of October.
The National Institute for Health and Care Excellence and the Public Health England have issued guidance on impetigo.
Literature update highlights the treatment methods, clinical pearls, and enhancement of outcomes for the disease.
Investigators suggested the prevention of exposure during pregnancy could help control atopic dermatitis and other potential allergies in pediatric populations.
A previous analysis found the vaccine was 90.7 percent effective against severe COVID-19.
Most respondents look online when finding a physician or other care entity.
Combined therapies such as ultraviolet light and tab methotrexate were deemed effective in the management of vitiligo.